Comparative Pharmacology
Head-to-head clinical analysis: CUPRIC CHLORIDE IN PLASTIC CONTAINER versus MANGANESE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CUPRIC CHLORIDE IN PLASTIC CONTAINER versus MANGANESE SULFATE.
CUPRIC CHLORIDE IN PLASTIC CONTAINER vs MANGANESE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Copper is an essential trace element that serves as a cofactor for numerous enzymes, including cytochrome c oxidase, superoxide dismutase, ceruloplasmin, lysyl oxidase, and dopamine beta-hydroxylase. It is critical for mitochondrial respiration, antioxidant defense, connective tissue cross-linking, neurotransmitter synthesis, and iron homeostasis. Cupric chloride provides ionic copper for these physiological processes.
Manganese sulfate is a source of manganese, a trace element that acts as a cofactor for various enzymes including arginase, pyruvate carboxylase, and superoxide dismutase. It is essential for normal bone formation, blood clotting, and nervous system function.
0.5-2.5 mg copper per day intravenously as a supplement to parenteral nutrition.
Intravenous: 0.1-0.2 mg manganese/kg/day (as manganese sulfate) added to TPN. Maximum 0.15-0.8 mg/day. Injection IV: 0.1-0.2 mg manganese/kg/day.
None Documented
None Documented
Terminal elimination half-life of copper is approximately 2-4 weeks (13-28 days) in humans, reflecting slow turnover from tissue stores, particularly liver and brain. This long half-life is clinically important for cumulative toxicity risk.
Terminal elimination half-life approximately 37 days (range 30–45 days) in whole body; reflects slow turnover in tissues, especially bone and liver. Clinical context: Accumulation occurs with chronic high exposure or impaired biliary excretion (e.g., hepatic disease).
Primarily renal; approximately 80% of absorbed copper is excreted in bile, with fecal loss accounting for the majority (about 80-90%) of total elimination. Urinary excretion is minimal (<5%) under normal conditions.
Primarily fecal (biliary) elimination of unabsorbed manganese; absorbed manganese is excreted mainly in bile (99%) with minimal renal excretion (<1%). Small amounts secreted in pancreatic juice and reabsorbed enterally.
Category C
Category C
Mineral Supplement
Mineral Supplement